Radoslaw Jadczak, MD, MBA Director, Strategic Site Solutions, Early Phase
IQVIA, (Poland)
Dr. Jadczak is responsible for leading the European Early Phase Oncology Network of sites dedicated to Phase I/II solid tumor and hematology trials. He has used his expertise in drug development strategy, knowledge of clinical research methods and understanding of medical science and the therapeutic landscape to shape design and delivery strategies for oncology studies and programs that meet the needs and expectations of Sponsors. He has provided therapeutic strategy input for many cancer indications and trial designs across Phase FIH to IIIb, including adaptive designs, basket studies and biosimilar interchangeability. Dr. Jadczak is responsible for leading the European Early Phase Oncology Network of sites dedicated to Phase I/II solid tumor and hematology trials.